Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.507 SEK | -1.93% | -0.59% | +11.06% |
03:53pm | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
May. 08 | Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ACTI Stock
- News Active Biotech AB
- Analyst Reco.